CANNSUN ANNOUNCES EXECUTED LETTER OF INTENT TO ACQUIRE PERSONALISED WELLNESS COMPANY APPHIA LABORATORIES
DUBLIN, IRELAND , November 10, 2020 /EINPresswire.com/ — Cannsun, a bio-pharmaceutical company focused on developing and commercializing new medicines to optimize human potential with operations in South Africa, Greece, Thailand and Lesotho, today announced its letter of intent to acquire personalized, subscription-based natural botanical wellness company Apphia Laboratories and has appointed Apphia founder Dr. Michel […]